רספרים

देश: इसराइल

भाषा: हिब्रू

स्रोत: Ministry of Health

सक्रिय संघटक:

SULPHAMETHOXAZOLE; TRIMETHOPRIM

थमां उपलब्ध:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ए.टी.सी कोड:

J01EE01

फार्मास्यूटिकल फॉर्म:

תרחיף

रचना:

SULPHAMETHOXAZOLE 200 MG / 5 ML; TRIMETHOPRIM 40 MG / 5 ML

प्रशासन का मार्ग:

פומי

प्रिस्क्रिप्शन प्रकार:

מרשם נדרש

द्वारा बनाया गया:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

चिकित्सीय समूह:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

चिकित्सीय क्षेत्र:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

चिकित्सीय संकेत:

Treatment of urinary tract infections due to susceptible strains of the following organisms: - Escherichia coli - Klebsiella - Enterobacter - Proteus mirabilis - Proteus vulgaris - Proteus morganii. Treatment of acute otitis media in children due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. To date there are limited data available as to the safety of repeated use of Resprim in infants under 2 years of age. Resprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. Treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei. Resprim is also indicated in the treatment of documented Pneumocystis carinii pneumonitis.

प्राधिकरण की तारीख:

2012-01-31